SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Cyclacel Pharmaceuticals, Inc. Announces Publication of Phase 2 Results for Sapacitabine in Elderly AML Patients in the Lancet Oncology